JRGD:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) (EUR)

ETF | Others |

Last Closing

USD 40.95

Change

0.00 (0.00)%

Market Cap

USD 2.00M

Volume

666.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.04 (-0.08%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.05%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.10%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.09%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.05 (-0.21%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+0.58 (+0.38%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+0.64 (+0.46%)

USD 102.14B
JARI:XETRA Amundi Index Solutions - Amund..

+0.15 (+0.34%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.04 (-0.07%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.32 (+0.26%)

USD 80.38B

ETFs Containing JRGD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.58% 81% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.58% 81% B- 78% C+
Trailing 12 Months  
Capital Gain 24.24% 82% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.24% 82% B 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.28% 56% F 55% F
Dividend Return 5.28% 55% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.62% 67% D+ 74% C
Risk Adjusted Return 61.22% 78% C+ 79% B-
Market Capitalization 2.00M 2% F 1% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.